Abstract
VERTEBRATES constantly remodel bone. The resorption of preexisting bone by osteoclasts and the formation of new bone by osteoblasts is strictly coordinated to maintain bone mass within defined limits. A few molecular determinants of bone remodelling that affect osteoclast activity1–3 have been characterized, but the molecular determinants of osteoblast activity are unknown. To investigate the role of osteocalcin, the most abundant osteoblast-specific non-collagenous protein4, we have generated osteocalcin-deficient mice. These mice develop a phenotype marked by higher bone mass and bones of improved functional quality. Histomorphometric studies done before and after ovariectomy showed that the absence of osteocalcin leads to an increase in bone formation without impairing bone resorption. To our knowledge, this study provides the first evidence that osteocalcin is a determinant of bone formation.
This is a preview of subscription content
Access options
Subscribe to Journal
Get full journal access for 1 year
204,58 €
only 4,01 € per issue
Tax calculation will be finalised during checkout.
Buy article
Get time limited or full article access on ReadCube.
$32.00
All prices are NET prices.
References
Soriano, P., Montgomery, C., Geske, R. & Bradley, A. Cell 64, 693–702 (1991).
Wang, Z-Q. et al. Nature 360, 741–745 (1992).
Grigoriadis, A. E. et al. Science 266, 443–448 (1994).
Hauschka, P., Lian, J., Cole, D. & Gundberg, C. Physiol. Rev. 69, 990–1047 (1989).
Weinreb, M., Shinar, D. & Rodan, G. A. J. Bone Miner. Res. 5, 831–842 (1990).
Boivin, G. et al. Virchows Arch. A. Path. Anat. 417, 505–512 (1990).
Desbois, C., Hogue, D. A. & Karsenty, G. J. biol. Chem. 269, 1183–1190 (1994).
Bonadio, F. et al. Proc. natn. Acad. Sci. U.S.A. 87, 7145–7149 (1990).
Poli, V. et al. EMBO J. 13, 1189–1196 (1994).
Parfitt, A. M. et al. J. Bone Miner. Res. 2, 595–610 (1987).
Parfitt, A. M. et al. J. Clin. Invest. 72, 1396–1409 (1983).
Parfitt, A. M., Riggs, B. L. & Melton, L. J. Osteoporosis: Etiology, Diagnosis and Management. (eds Parfitt, A. M., Riggs, B. L. & Melton, L J.) 501 (Raven, New York, 1988).
Bain, S. D., Bailey, M. C., Celino, D. L., Lantry, M. M. & Edwards, M. W. J. Bone Miner. Res. 8, 435–442 (1993).
Stitt, T. N. et al. Cell 80, 661–670 (1995).
Coughlin, S. Thromb. Haemost. 70, 184–187 (1993).
McMahon, A. P. & Bradley, A. Cell 62, 1073–1085 (1990).
Luo, G., D'Souza, R., Hogue, D. & Karsenty, G. J. Bone Miner. Res. 10, 325–334 (1995).
Oldberg, A., Franzen, A. & Heinegard, D. Proc. natn. Acad. Sci. U.S.A. 83, 8819–8823 (1986).
Ramirez-Solis, R., Davis, A. & Bradley, A. Meth. Enzym. 225, 855–878 (1993).
Bradley, A. Teratocarcinomas and Embryonic Stem Cells: A Practical Approach (ed. Robinson, E. J.) 113–151 (IRL, Oxford, 1987).
Gundberg, C., Hauschka, P., Lian, J. & Gallop, P. M. Meth. Enzym. 107, 516–566 (1984).
Vignery, A. & Baron, R. Anat. Rec. 196, 191–200 (1980).
Andersson, G. N. & Marks, S. J. J. Histochem. Cytochem. 37, 115–117 (1989).
Boyce, B. F., Yoneda, T., Lowe, C., Soriano, P. & Mundy, G. R. J. Clin. Invest. 90, 1622–1627 (1992).
Jilka, R. L. et al. Science 257, 88–91 (1992).
Author information
Affiliations
Rights and permissions
About this article
Cite this article
Ducy, P., Desbois, C., Boyce, B. et al. Increased bone formation in osteocalcin-deficient mice. Nature 382, 448–452 (1996). https://doi.org/10.1038/382448a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/382448a0
Further reading
-
Matrix vesicles from dental follicle cells improve alveolar bone regeneration via activation of the PLC/PKC/MAPK pathway
Stem Cell Research & Therapy (2022)
-
Impaired bone healing by enoxaparin via inhibiting the differentiation of bone marrow mesenchymal stem cells towards osteoblasts
Journal of Bone and Mineral Metabolism (2022)
-
Adipogenic progenitors in different organs: Pathophysiological implications
Reviews in Endocrine and Metabolic Disorders (2022)
-
Role of Vitamin K in Bone and Muscle Metabolism
Calcified Tissue International (2022)
-
Aldo-keto reductase family 1 member C1 regulates the osteogenic differentiation of human ASCs by targeting the progesterone receptor
Stem Cell Research & Therapy (2021)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.